0001181431-13-062018.txt : 20131209 0001181431-13-062018.hdr.sgml : 20131209 20131209191007 ACCESSION NUMBER: 0001181431-13-062018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131205 FILED AS OF DATE: 20131209 DATE AS OF CHANGE: 20131209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HORIZON PHARMA, INC. CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272179987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 LAKE COOK ROAD STREET 2: SUITE 520 CITY: DEERFIELD STATE: IL ZIP: 60062 BUSINESS PHONE: 224-383-3000 MAIL ADDRESS: STREET 1: 520 LAKE COOK ROAD STREET 2: SUITE 520 CITY: DEERFIELD STATE: IL ZIP: 60062 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH TODD N CENTRAL INDEX KEY: 0001523672 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 131266738 MAIL ADDRESS: STREET 1: 1033 SKOKIE BOULEVARD STREET 2: SUITE 355 CITY: NORTHBROOK STATE: IL ZIP: 60062 4 1 rrd396913.xml X0306 4 2013-12-05 0 0001492426 HORIZON PHARMA, INC. HZNP 0001523672 SMITH TODD N C/O HORIZON PHARMA, INC. 520 LAKE COOK ROAD, SUITE 520 DEERFIELD IL 60015 0 1 0 0 EVP & Chief Commercial Officer Common Stock 2013-12-05 4 A 0 18037 0.0 A 48933 D Common Stock 2013-12-09 4 M 0 3350 0 A 52283 D Common Stock 2013-12-09 4 S 0 1322 6.79 D 50961 D Common Stock 2013-12-09 4 S 0 10000 6.93 D 40961 D Restricted stock units 2013-12-09 4 M 0 3350 0 D common stock 10048 6698 D Fully vested deferred issuance of restricted stock units provided as a one-time bonus payment in connection with the completion of the Company's acquisition of U.S. rights to VIMOVO (R). Includes 8,326 shares of the Company's common stock acquired in June 2013 and December 2013 pursuant to an employee stock purchase program. Reflects shares of common stock surrendered via open market sale to satisfy tax withholding obligations in connection with vesting of a restricted stock unit and the receipt of a fully vested deferred issuance stock award. Each restricted stock units represents a contingent right to receive one share of Horizon Pharma, Inc. common stock. On December 8, 2011, the reporting person was granted 13,397 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Robert J. DeVaere, Attorney-In-Fact 2013-12-09